These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 28978686)

  • 61. Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières.
    Yun O; Lima MA; Ellman T; Chambi W; Castillo S; Flevaud L; Roddy P; Parreño F; Albajar Viñas P; Palma PP
    PLoS Negl Trop Dis; 2009 Jul; 3(7):e488. PubMed ID: 19582142
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chagas Immunochromatographic Rapid Test in the Serological Diagnosis of
    Rodrigues ES; Santos GQ; da Silva MV; Barros JHS; Bernardo AR; Diniz RL; Rubim NM; Roque ALR; Jansen AM; Silva ED; Xavier SCC
    Front Cell Infect Microbiol; 2022; 12():835383. PubMed ID: 35273924
    [No Abstract]   [Full Text] [Related]  

  • 63. Efficacy of novel benznidazole solutions during the experimental infection with Trypanosoma cruzi.
    Manarin R; Lamas MC; Bottasso E; Serra E; Revelli S; Salomón CJ
    Parasitol Int; 2013 Feb; 62(1):79-81. PubMed ID: 22975280
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Benznidazole treatment in chronic children infected with Trypanosoma cruzi: serological and molecular follow-up of patients and identification of Discrete Typing Units.
    Rumi MM; Pérez Brandán C; Gil JF; D'Amato AM; Ragone PG; Lauthier JJ; Tomasini N; Cimino RO; Orellana V; Lacunza CD; Nasser JR; Basombrío MA; Diosque P
    Acta Trop; 2013 Oct; 128(1):130-6. PubMed ID: 23880286
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Anti-F2/3 antibodies as cure marker in children with congenital Trypanosoma cruzi infection].
    Altcheh J; Corral R; Biancardi MA; Freilij H
    Medicina (B Aires); 2003; 63(1):37-40. PubMed ID: 12673959
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Human antibody responses to Trypanosoma cruzi 70-kD heat-shock proteins.
    Krautz GM; Peterson JD; Godsel LM; Krettli AU; Engman DM
    Am J Trop Med Hyg; 1998 Feb; 58(2):137-43. PubMed ID: 9502594
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Levels of anti-B13 antibodies over time in a cohort of chronic infected by Trypanosoma cruzi. Its relationship with specific treatment and clinical status.
    Olivera V; Bizai ML; Arias E; Suasnabar S; Bottasso O; Marcipar I; Fabbro D
    Acta Trop; 2021 Jun; 218():105908. PubMed ID: 33789152
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of a chemiluminescent enzyme-linked immunosorbent assay for the diagnosis of Trypanosoma cruzi infection in a nonendemic setting.
    Izquierdo L; Marques AF; Gállego M; Sanz S; Tebar S; Riera C; Quintó L; Aldasoro E; Almeida IC; Gascon J
    Mem Inst Oswaldo Cruz; 2013 Nov; 108(7):928-31. PubMed ID: 24271047
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia.
    Bianchi F; Cucunubá Z; Guhl F; González NL; Freilij H; Nicholls RS; Ramírez JD; Montilla M; Flórez AC; Rosas F; Saavedra V; Silva N
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003465. PubMed ID: 25723465
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of peptide-based lineage-specific serology for chronic Chagas disease: geographical and clinical distribution of epitope recognition.
    Bhattacharyya T; Falconar AK; Luquetti AO; Costales JA; Grijalva MJ; Lewis MD; Messenger LA; Tran TT; Ramirez JD; Guhl F; Carrasco HJ; Diosque P; Garcia L; Litvinov SV; Miles MA
    PLoS Negl Trop Dis; 2014 May; 8(5):e2892. PubMed ID: 24852444
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High throughput selection of effective serodiagnostics for Trypanosoma cruzi infection.
    Cooley G; Etheridge RD; Boehlke C; Bundy B; Weatherly DB; Minning T; Haney M; Postan M; Laucella S; Tarleton RL
    PLoS Negl Trop Dis; 2008 Oct; 2(10):e316. PubMed ID: 18841200
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment of Trypanosoma cruzi-infected children with nifurtimox: a 3 year follow-up by PCR.
    Solari A; Ortíz S; Soto A; Arancibia C; Campillay R; Contreras M; Salinas P; Rojas A; Schenone H
    J Antimicrob Chemother; 2001 Oct; 48(4):515-9. PubMed ID: 11581230
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Congenital Chagas' disease: diagnostic and clinical aspects.
    Freilij H; Altcheh J
    Clin Infect Dis; 1995 Sep; 21(3):551-5. PubMed ID: 8527542
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Enzyme-linked immunosorbent assay for serological diagnosis of Chagas' disease employing a Trypanosoma cruzi recombinant antigen that consists of four different peptides.
    Ferreira AW; Belem ZR; Lemos EA; Reed SG; Campos-Neto A
    J Clin Microbiol; 2001 Dec; 39(12):4390-5. PubMed ID: 11724850
    [TBL] [Abstract][Full Text] [Related]  

  • 75. High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina.
    Sánchez Negrette O; Mora MC; Basombrío MA
    Pediatrics; 2005 Jun; 115(6):e668-72. PubMed ID: 15930194
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Performance of different Trypanosoma cruzi antigens in the diagnosis of Chagas disease in patients with American cutaneous leishmaniasis from a co-endemic region in Argentina.
    Vega Benedetti AF; Cimino RO; Cajal PS; Juarez MDV; Villalpando CA; Gil JF; Marcipar IS; Krolewiecki AJ; Nasser JR
    Trop Med Int Health; 2013 Sep; 18(9):1103-1109. PubMed ID: 23837449
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Diagnosis of Congenital Chagas Disease Using an Iron Superoxide Dismutase Excreted as Antigen, in Mothers and Their Children During the First Year of Life.
    Concha Valdez F; Marín C; Flores Abuxapqui J; Escobedo Ortegón J; Cañas R; Sánchez Moreno M
    Pediatr Infect Dis J; 2016 Jul; 35(7):739-43. PubMed ID: 27088584
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Enzyme-linked immunosorbent assay for IgA antibodies to Trypanosoma cruzi in congenital infection.
    Di Pentima MC; Edwards MS
    Am J Trop Med Hyg; 1999 Feb; 60(2):211-4. PubMed ID: 10072138
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Flow cytometry, a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas' disease.
    Martins-Filho OA; Pereira ME; Carvalho JF; Cançado JR; Brener Z
    Clin Diagn Lab Immunol; 1995 Sep; 2(5):569-73. PubMed ID: 8548536
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Trypomastigote Excretory Secretory Antigen Blot Is Associated With Trypanosoma cruzi Load and Detects Congenital T. cruzi Infection in Neonates, Using Anti-Shed Acute Phase Antigen Immunoglobulin M.
    Noazin S; Lee JA; Malaga ES; Valencia Ayala E; Condori BJ; Roca C; Lescano AG; Bern C; Castillo W; Mayta H; Menduiña MC; Verastegui MR; Tinajeros F; Gilman RH;
    J Infect Dis; 2019 Jan; 219(4):609-618. PubMed ID: 30252099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.